Whitehouse Station, NJ, drugmaker Merck has a renewed focus on cardiovascular treatments and Thursday nabbed an FDA approval for a drug that will move that emphasis down the road.
written on 09.05.2014
Whitehouse Station, NJ, drugmaker Merck has a renewed focus on cardiovascular treatments and Thursday nabbed an FDA approval for a drug that will move that emphasis down the road.
See our Cookie Privacy Policy Here